Porcine Vaccine Market Forecast 2026–2035 Driven by Industry Growth Factors

April 8, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Increase Is Anticipated For The Anti-Inflammatory Biologics Market Over The 2026–2030 Period?

The porcine vaccine market has experienced substantial growth in recent years. Its valuation is expected to climb from $2.05 billion in 2025 to $2.25 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 9.4%. The expansion observed historically is due to factors such as outbreaks of swine diseases, increasing pork consumption, the development of traditional vaccines, greater veterinary awareness, and the growth of hog farming infrastructure.

The porcine vaccine market is anticipated to show significant expansion in the coming years, with projections indicating it will achieve a size of $3.22 billion in 2030, advancing at a compound annual growth rate (CAGR) of 9.4%. This growth over the forecast period is propelled by factors such as the development of recombinant and DNA vaccines, the adoption of precision veterinary medicine, an intensified focus on herd immunity programs, technological progress in vaccine delivery systems, and increasing government support for livestock health. Noteworthy trends during this time include the integration of multi-strain vaccines for pigs, a stronger emphasis on disease prevention within swine herds, increased financial backing for swine immunization initiatives, the incorporation of veterinary advisory services with farms, and the expansion of the cold chain infrastructure essential for vaccine distribution.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9111&type=smp

Which Major Factors Are Driving The Expansion Of The Anti-Inflammatory Biologics Market?

The escalating consumption of pork is anticipated to drive the expansion of the porcine vaccine market in the upcoming period. Pork consumption is defined as the amount of pork meat eaten by individuals or groups over a specific timeframe. The intake of pork has grown in parallel with the increasing global population and the rising demand for protein. The porcine vaccine market contributes to this heightened pork consumption by preventing diseases in pigs, improving the health of herds, and securing a steady provision of safe and high-quality pork products. As an illustration, in July 2024, information from INAPORC (Interprofession Nationale Porcine), a national pork association located in France, revealed that in 2023, pork continued to be the most consumed meat in France, at about 30.6 kg per person per year. Thus, the increasing consumption of pork is a key factor propelling the growth of the porcine vaccine market.

How Is The Anti-Inflammatory Biologics Market Segmented Across Key Categories?

The porcine vaccine market covered in this report is segmented –

1) By Technology: Inactivated Vaccines, Live Attenuated Vaccines, Toxoid Vaccines, Recombinant Vaccines, Conjugate Vaccines, DNA Vaccines

2) By Disease Indication: Diarrhea, Swine Influenza, Arthritis, Bordetella Rhinitis, Porcine Reproductive and Respiratory Virus (PRRSV), Porcine Circovirus Associated Disease (PCVAD), Other Disease Indications

3) By End User: Veterinary Hospitals, Hog Or Pig Production Farm

Subsegments:

1) By Inactivated Vaccines: Whole Virus Inactivated Vaccines, Subunit Inactivated Vaccines

2) By Live Attenuated Vaccines: Live Modified Vaccines, Live Virulent Vaccines

3) By Toxoid Vaccines: Inactivated Toxins

4) By Recombinant Vaccines: Recombinant Vector Vaccines, Subunit Recombinant Vaccines

5) By Conjugate Vaccines: Polysaccharide Conjugate Vaccines

6) By DNA Vaccines: Plasmid DNA Vaccines

Which Upcoming Trends Are Expected To Influence The Porcine Vaccine Market?

Leading companies in the porcine vaccine market are forming strategic alliances to boost their research and development efforts and reinforce their competitive standing in the rapidly changing animal health industry. This collaborative approach leverages TVG’s expertise in vaccine technology and Pirbright’s specialized knowledge in African swine fever (ASF) research. The primary aim of such partnerships is to refine the vaccine development process and introduce novel methods that promise significant improvements in swine health. As an illustration, in May 2024, The Pirbright Institute, a research organization situated in the UK, joined forces with The Vaccine Group (TVG), a UK-based firm, to create an African swine fever (ASF) vaccine. This research endeavors to formulate vaccines to prevent African swine fever (ASF) using bovine herpesvirus 4 (BoHV-4) as a base. This methodology capitalizes on the latest advancements in ASF vaccine research and pig immunology to engineer more effective vaccines. The initiative receives funding from the U.K.’s Department for Environment, Food and Rural Affairs (Defra) and the Biotechnology and Biological Sciences Research Council (BBSRC).

Who Are The Dominant Players Shaping The Anti-Inflammatory Biologics Market Landscape?

Major companies operating in the porcine vaccine market are Sanofi Pasteur Inc., Boehringer Ingelheim International GmbH, Zoetis Inc., Merck Animal Health, Elanco Animal Health Incorporated, Ceva Santé Animale, Huvepharma Inc., Phibro Animal Health Corporation, Vetoquinol SA, Intervet Inc., HIPRA S.A., IDT Biologika GmbH, Biogénesis Bagó, Aptimmune Biologics Inc., Virbac S.A., Vaxxinova International BV, Bioveta a.s., Indian Immunologicals Limited, KM Biologics, Addison Biological Laboratory, Colorado Serum Company, CAHIC China Animal Husbandry Industry Co, Tecon, Hile Bio, WINSUN

Read the full porcine vaccine market report here:

https://www.thebusinessresearchcompany.com/report/porcine-vaccine-global-market-report

Which Region Currently Holds The Largest Share Of The Anti-Inflammatory Biologics Market?

North America is the largest region in the porcine vaccine market in 2025. The regions covered in the porcine vaccine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Anti-Inflammatory Biologics Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=9111&type=smp

Browse Through More Reports Similar to the Global Porcine Vaccine Market 2026, By The Business Research Company

Porcine Epidemic Diarrhea Vaccines Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/porcine-epidemic-diarrhea-vaccines-global-market-report

Swine Vaccines Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/swine-vaccines-global-market-report

Veterinary Vaccines Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/veterinary-vaccines-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795